Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.

MacMahon S, Collins R.

Lancet. 2001 Feb 10;357(9254):455-62. Review.

PMID:
11273081
2.

How to anticipate the assessment of the public health benefit of new medicines?

Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII.

Therapie. 2007 Sep-Oct;62(5):427-35. doi: 10.2515/therapie:2007071. Epub 2008 Jan 19.

PMID:
18206104
3.

Using routine data to complement and enhance the results of randomised controlled trials.

Lewsey JD, Leyland AH, Murray GD, Boddy FA.

Health Technol Assess. 2000;4(22):1-55.

4.

[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].

Oparil S, Bakir SE.

Drugs. 2000;59 Spec No 2:25-37. Review. French.

PMID:
11002856
5.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.

Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.

6.
7.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
8.

[Controlled randomized clinical trials].

Jaillon P.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):739-56; discussion 756-8. French.

PMID:
18225427
9.

Megatrials of drug treatments: strengths and limitations.

Heng D.

Ann Acad Med Singapore. 2000 Sep;29(5):606-9.

PMID:
11126695
10.

Coil embolization for intracranial aneurysms: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(1):1-114. Epub 2006 Jan 1.

11.

Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD010257. doi: 10.1002/14651858.CD010257. Review.

PMID:
23235687
12.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

PMID:
23235644
13.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

14.

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

Collins R, MacMahon S.

Lancet. 2001 Feb 3;357(9253):373-80. Review.

PMID:
11211013
17.

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

Halliday HL, Ehrenkranz RA, Doyle LW.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001146. doi: 10.1002/14651858.CD001146.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;5:CD001146.

PMID:
20091516
18.

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

Halliday HL, Ehrenkranz RA, Doyle LW.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001146. doi: 10.1002/14651858.CD001146.pub2. Review.

PMID:
19160190
19.

Practice-based evidence research in rehabilitation: an alternative to randomized controlled trials and traditional observational studies.

Horn SD, DeJong G, Deutscher D.

Arch Phys Med Rehabil. 2012 Aug;93(8 Suppl):S127-37. doi: 10.1016/j.apmr.2011.10.031.

PMID:
22840879

Supplemental Content

Support Center